Literature DB >> 7523697

Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV.

E Rieder1, B Baxt, J Lubroth, P W Mason.   

Abstract

The G-H loop of VP1 (residues 132 to 159) of foot-and-mouth disease virus (FMDV) is a prominent feature on the virion surface and has an important role in vaccine efficacy, generation of antigenic variants, and cell binding. Using an infectious cDNA of FMDV, we have constructed serotype A viruses in which the G-H loop has been substituted with the homologous sequences from serotype O or C. These chimeric viruses replicated to high titer and displayed plaque morphologies similar to those of wild-type viruses, demonstrating that the functions provided by the loop can be readily exchanged between serotypes. Monoclonal antibody analyses showed that epitopes contained within the loop were transferred to the chimeras and that epitopes encoded by the type A backbone were maintained. Chemically inactivated vaccines prepared from chimeric viruses induced antibodies in guinea pigs that neutralized both type A and either type O or type C viruses. Swine inoculated with the A/C chimera vaccine also produced cross-reactive antibodies, were protected from challenge with the type A virus, and partially protected against challenge with type C. These studies emphasize the importance of epitopes outside of the G-H loop in protective immunity in swine, which is a natural host of FMDV.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523697      PMCID: PMC237147     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Antigenic structure of chimeras of type 1 and type 3 poliovirus involving antigenic site 1.

Authors:  P D Minor; M Ferguson; K Katrak; D Wood; A John; J Howlett; G Dunn; K Burke; J W Almond
Journal:  J Gen Virol       Date:  1990-11       Impact factor: 3.891

2.  Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus.

Authors:  T R Doel; C Gale; C M Do Amaral; G Mulcahy; R Dimarchi
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites.

Authors:  J D Kitson; D McCahon; G J Belsham
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

4.  A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.

Authors:  M G Mateu; M A Martínez; L Capucci; D Andreu; E Giralt; F Sobrino; E Brocchi; E Domingo
Journal:  J Gen Virol       Date:  1990-03       Impact factor: 3.891

5.  Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus.

Authors:  N Parry; G Fox; D Rowlands; F Brown; E Fry; R Acharya; D Logan; D Stuart
Journal:  Nature       Date:  1990-10-11       Impact factor: 49.962

6.  Chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs.

Authors:  J D Kitson; K L Burke; L A Pullen; G J Belsham; J W Almond
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

7.  Amino acid changes outside the G-H loop of capsid protein VP1 of type O foot-and-mouth disease virus confer resistance to neutralization by antipeptide G-H serum.

Authors:  O Krebs; R Ahl; O C Straub; O Marquardt
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

Review 8.  The carrier state in foot and mouth disease--an immunological review.

Authors:  J S Salt
Journal:  Br Vet J       Date:  1993 May-Jun

9.  Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants.

Authors:  J R Crowther; S Farias; W C Carpenter; A R Samuel
Journal:  J Gen Virol       Date:  1993-08       Impact factor: 3.891

10.  Structure of a major immunogenic site on foot-and-mouth disease virus.

Authors:  D Logan; R Abu-Ghazaleh; W Blakemore; S Curry; T Jackson; A King; S Lea; R Lewis; J Newman; N Parry
Journal:  Nature       Date:  1993-04-08       Impact factor: 49.962

View more
  14 in total

1.  Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine.

Authors:  G Ward; E Rieder; P W Mason
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle.

Authors:  D Sa-Carvalho; E Rieder; B Baxt; R Rodarte; A Tanuri; P W Mason
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates.

Authors:  S S Whitehead; M G Hill; C Y Firestone; M St Claire; W R Elkins; B R Murphy; P L Collins
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  RGD tripeptide of bluetongue virus VP7 protein is responsible for core attachment to Culicoides cells.

Authors:  B H Tan; E Nason; N Staeuber; W Jiang; K Monastryrskaya; P Roy
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.

Authors:  P R Grigera; M Garcia-Briones; O Periolo; J L la Torre; R R Wagner
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins.

Authors:  Hernando Duque; Michael LaRocco; William T Golde; Barry Baxt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses.

Authors:  Hernando Duque; Barry Baxt
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

8.  Megaprimer-mediated capsid swapping for the construction of custom-engineered chimeric foot-and-mouth disease virus.

Authors:  Jitendra K Biswal; Saravanan Subramaniam; Gaurav K Sharma; Sonalika Mahajan; Rajeev Ranjan; Jyoti Misri; Bramhadev Pattnaik
Journal:  Virus Genes       Date:  2015-08-25       Impact factor: 2.332

9.  Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD.

Authors:  T S McKenna; J Lubroth; E Rieder; B Baxt; P W Mason
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  A Novel Plasmid DNA-Based Foot and Mouth Disease Virus Minigenome for Intracytoplasmic mRNA Production.

Authors:  Ploypailin Semkum; Challika Kaewborisuth; Nattarat Thangthamniyom; Sirin Theerawatanasirikul; Chalermpol Lekcharoensuk; Payuda Hansoongnern; Pongrama Ramasoota; Porntippa Lekcharoensuk
Journal:  Viruses       Date:  2021-06-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.